Telemedica

Name

Telemedica

Legal name

株式会社テレメディカ

Website

https://telemedica.jp

Company type

Private

Founded year

2012

Operating status

Operating

Headcount range

1–10 employees

Ownership category

akta.pro rank

Product category

Medical Education Technology

NAICS

Electromedical and Electrotherapeutic Apparatus Manufacturing (334510), Educational Support Services (61171)

SIC

Electromedical & Electrotherapeutic Apparatus (3845), Services-Prepackaged Software (7372)

akta.pro primary industry

Telehealth & Digital Wellness Services (EDALAFAM)

Keywords

• Medical education technology
• Auscultation training systems
• Virtual clinical simulation
• Medical e-learning platforms
• Diagnostic training software

Headquarters

HQ city

Yokohama

HQ country

Japan

HQ region

Asia

Offices4 records

Markets served

GTM type

B2B

Offering type

Software

Cost components

Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure

Revenue model

1. Kikuzo Hardware Sales: Kikuzo is an auscultation speaker sold as a physical hardware product. Pre-sale began in 2017. International sales contracts have been concluded with distributors in multiple regions (BT Inc. globally, YOUNG TAH for Taiwan/China, Impresa for Russia/CIS, GN Corporation for India, Gokei Trading for China).
2. iPax / Kikuzo to Academic Societies: Telemedica provides iPax free of charge to academic societies. This drives adoption and brand recognition in the academic medical community, potentially leading to broader institutional purchasing.
3. Ausculaide App (iOS/Android): Ausculaide is a free-to-download smartphone app with in-app purchase functionality for individual consumers through iOS and Android app stores.
4. iPax PowerPoint Version: iPax PowerPoint version made available free of charge as a distribution and awareness tool.
5. International Distribution Agreements: Revenue generated through international sales contracts with regional distributors (BT Inc., YOUNG TAH CO., LTD., Impresa Ltd., GN Corporation, Gokei Trading Corporation) who purchase or license Kikuzo and iPax for resale in their respective territories.

Pricing tiers

Go-to-market motion3 records

Distribution channels11 records

Marketing channels8 records

Core offering

Telemedica develops virtual auscultation education systems for medical and nursing students, centered on the iPax cloud-based virtual auscultation simulator and the Kikuzo dedicated auscultation speaker. Its core technology uses proprietary frequency analysis of recorded auscultation sounds to isolate pure heart and lung sound components from noise. The company also offers the Ausculaide smartphone app for individual learners and provides free iPax access to academic societies to drive institutional adoption.

Product overview

Telemedica offers a suite of medical auscultation education products centered around two core offerings: Kikuzo (a dedicated speaker for reproducing realistic auscultation sounds) and iPax (a cloud-based virtual auscultation simulator). These are complemented by add-on modules including iPax Log Management for content administration, iPax Monitoring for real-time student screen tracking, and QR-iPax for QR code-based case distribution. Ausculaide provides a mobile application alternative for smartphone users. The ecosystem enables medical students and professionals to practice auscultation skills anytime, anywhere, with administrators able to track usage and learning outcomes.

Differentiator

Problem solved

Functional benefit

Products and services

• Kikuzo (Auscultation Speaker) A dedicated hardware speaker that reproduces realistic heart and lung auscultation sounds at the same frequency as a living body; users listen with their own stethoscope and can palpate pulses and thrills. Designed for medical and nursing education institutions.
• iPax (Virtual Auscultation Simulator) A cloud-based virtual auscultation simulator that allows learners to study auscultation on their own smartphone or computer; administrators can check student usage history and quiz correct answer rates on an admin page.
• Ausculaide (Smartphone App)

Quantifiable outcome

• 92% satisfaction rate (71% extremely satisfied, 21% satisfied) at Japan Society of Early Mobilization hands-on session with 141 participants
• +4 more outcomes

Named customers8 records

Segments4 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature7 records

Partnerships

Eleven partnerships are on record, tiered core, minor and flagship.

• Professor Takeshi Saraya (Kyorin University)coreStrategic or Co-development Partner · 24 February 2026Dr. Takeshi Saraya authored a paper on Mycoplasma pneumonia published in Journal of Clinical Medicine (Saraya T.; J. Clin. Med. 2026, 15(4), 1644) with embedded iPax QR codes, integrating the iPax platform into academic publication.
• Japan Society of Early MobilizationminorStrategic or Co-development Partner · 24 June 2023iPax used in hands-on session at Japan Society of Early Mobilization annual meeting (June 24, 2023). 141 attendees, 92% satisfaction rate.
• Japanese Educational Clinical Cardiology Society (JECCS)coreStrategic or Co-development Partner · 25 February 2023Conducted cardiovascular specialist nurse training using iPax and Kikuzo. iPax QR codes about aortic stenosis distributed at the meeting.
• KeyvitcoreChannel Partner/ Reseller/ Distributor · 1 June 2022Consignment sales partner for iPax in the United States. Announced June 2022.
• Impresa Ltd.coreChannel Partner/ Reseller/ Distributor · 1 August 2021Sales contract for Kikuzo in Russia and CIS regions. Concluded August 2021.
• GN CorporationcoreChannel Partner/ Reseller/ Distributor · 1 August 2021Sales contract for Kikuzo and iPax in India. Concluded August 2021.
• Gokei Trading Corporation (互恵交易株式会社)coreChannel Partner/ Reseller/ Distributor · 1 January 2021Sales contract for Kikuzo and iPax in China. Concluded 2021.
• BT Inc.coreChannel Partner/ Reseller/ Distributor · 1 January 2020Global sales contract for Kikuzo auscultation speaker. Concluded in 2020. BT Inc. distributes Kikuzo internationally outside Japan.
• YOUNG TAH CO., LTD. (永達儀器有限公司)coreChannel Partner/ Reseller/ Distributor · 1 January 2020Taiwan and China sales contract for Kikuzo. Concluded in 2020.
• Japan External Trade Organization (JETRO)flagshipGTM or Marketing Partner · 1 January 2020Adopted JETRO Hands-on Support program for overseas expansion in 2020, 2021, and 2022 (three consecutive years). Exhibited iPax at EXPO 2025 Osaka-Kansai 'Japan Health' JETRO Pavilion (Company No. 29).
• National Center for Child Health and DevelopmentcoreStrategic or Co-development Partner · 1 January 2019Joint research contract concluded in 2019. Jointly developed an educational system for learning auscultation of neonates with the National Center for Child Health and Development (NCCHD), Tokyo. Published press release July 11, 2023.

Scale indicators4 records

Recent moves15 records

Expansion highlights8 records

Broad incumbents

• Laerdal Medical: Laerdal is the global leader in patient simulation (SimMan, SimBaby, Resusci Anne) and is used across most medical and nursing schools. While it covers a much broader portfolio, its simulation suites include auscultation capability that overlaps with Telemedica's offering.
• Nasco Healthcare: Nasco Healthcare (which absorbed Simulaids) offers a wide catalog of medical training manikins and task trainers, including auscultation trainers. It serves nursing and medical schools globally, overlapping with Telemedica's core customer segments.
• CAE Healthcare: CAE Healthcare provides a broad portfolio of patient simulators, ultrasound trainers, and learning solutions for medical education. Its high-fidelity simulators include heart/lung sound capability, putting it in broad overlap with Telemedica's iPax/Kikuzo for institutional simulation budgets.
• 3B Scientific: 3B Scientific is a global medical education and anatomy product company that acquired Cardionics. Through Cardionics it directly competes with Telemedica in auscultation, while its broader anatomy/skills portfolio competes for general medical training budgets.

Others

• HealthStream: HealthStream is a US healthcare workforce education and credentialing platform serving hospitals and nursing schools. While not a simulation vendor, it sits in the same healthcare continuing-education procurement channel and competes for the learning-management share of medical training budgets.

Direct peers

• Kyoto Kagaku: Kyoto Kagaku is a leading Japanese manufacturer of medical training simulators, including auscultation trainers used by Japanese medical schools. It competes head-to-head with Kikuzo for institutional procurement in Japan and is a natural direct peer given the same geography and customer base.
• Cardionics (a 3B Scientific company): Cardionics is the established specialist in auscultation training products (SAM manikin, SimScope), making it the closest direct competitor to Telemedica's Kikuzo/iPax. Both companies target medical/nursing schools with heart/lung sound education tools and compete for the same institutional budgets worldwide.

Emerging players

• Surgical Science: Surgical Science provides VR-based medical training simulations for surgery, endoscopy, and nursing procedures. While its core focus is procedural rather than auscultation, it represents a class of digital/screen-based medical education competitors that share Telemedica's PLG, cloud-based approach.
• Body Interact: Body Interact provides virtual patient simulators for medical and nursing education, with a cloud-based, screen-first delivery model similar to iPax. It is a partial-overlap digital competitor focused on clinical reasoning rather than auscultation specifically.
• FundamentalVR: FundamentalVR offers immersive VR surgical training with haptic feedback to medical institutions and device manufacturers. It is an adjacent digital medical-education player rather than a direct auscultation competitor, but competes for the same institutional digital-learning budgets.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

Compliance3 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles7 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Telemedica